Morgan Stanley Reduces Weigao Group Target Price to HK$4.5, Maintains Market Perform Rating

Stock News07-24

Morgan Stanley has released a research report indicating a reduction in the target price for Weigao Group (01066).

The investment bank has lowered its revenue forecasts for the company from 2026 to 2028 by 1% to 2%, reflecting persistent headwinds in the conventional consumables business from volume-based procurement (VBP) and competition, as well as the recent policy impact on the orthopedics segment. Morgan Stanley now expects overall revenue growth to be only in the low single digits.

Consequently, the bank has cut its earnings per share (EPS) estimates for Weigao Group for the 2026, 2027, and 2028 fiscal years by 11.8%, 12.6%, and 13.5%, respectively. The target price has been reduced from HK$5.2 to HK$4.5, while the "Market Perform" rating is maintained.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment